Eurofins Genomics Denmark A/S
CVR 10048818 · Public limited company (A/S) · Active · Low risk
Eurofins Genomics Denmark A/S is a Public limited company (A/S), founded on , based in Galten. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 0.1% over the next 12 months, which is 0.1 times the average for Danish companies. 20 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 14.2m and a net result of DKK -8.6m.
Bankruptcy risk for Eurofins Genomics Denmark A/S
0.1 × the average (1.41%) · higher risk than 38% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 10048818
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (26 years)
- Address
- Smedeskovvej 38
8464 Galten - Municipality
- Skanderborg
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 550k
- Employees
- 38 (2018)
- Auditor
- DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 25 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 9.9% |
| Current ratio | 121% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 1 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 30 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK 43.6m | DKK 36.8m |
| Net profit | DKK -8.6m | DKK -12.8m |
| Equity | DKK 14.2m | DKK -4.1m |
| Total assets | DKK 143.1m | DKK 175.3m |
| Cash | DKK 1.3m | – |
| Short-term debt | DKK 75.7m | – |
| Avg. employees | 64 | – |
Latest annual report: Reporting class C, mellemstor virksomhed · auditor's statement: Revisionspåtegning · Deloitte Statsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 154 | ||
| 1 Jan 2024 – 31 Dec 2024 | 154 | ||
| 1 Jan 2023 – 31 Dec 2023 | 179 | ||
| 1 Jan 2022 – 31 Dec 2022 | 159 | ||
| 1 Jan 2021 – 31 Dec 2021 | 139 | ||
| 1 Jan 2020 – 31 Dec 2020 | 165 | ||
| 1 Jan 2019 – 31 Dec 2019 | 175 | ||
| 1 Jan 2018 – 31 Dec 2018 | 147 | ||
| 1 Jan 2017 – 31 Dec 2017 | 163 | ||
| 1 Jan 2016 – 31 Dec 2016 | 164 | ||
| 1 Jan 2015 – 31 Dec 2015 | 155 | ||
| 1 Jan 2014 – 31 Dec 2014 | 148 | ||
| 1 Jan 2013 – 31 Dec 2013 | 135 | ||
| 1 Jan 2012 – 31 Dec 2012 | 62 | ||
| 1 Jan 2011 – 31 Dec 2011 | 80 | ||
| 1 Jan 2010 – 31 Dec 2010 | 93 | ||
| 1 Jan 2009 – 31 Dec 2009 | 146 | ||
| 1 Jan 2008 – 31 Dec 2008 | 148 | ||
| 1 Jan 2007 – 31 Dec 2007 | 142 | ||
| 1 Jan 2006 – 31 Dec 2006 | 134 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Torben Falck Ørntoft | ||
| Board | Svend Aage Linde | Current | |
| Board | Jacob Sickmann Ransborg | Current | |
| Board | Ulrich August Werner Kühle | Current | |
| Board | Torben Falck Ørntoft | ||
| Board | Jørn Renz Enggaard | ||
| Board | Mogens Kruhøffer | ||
| Board | Claus Thorsen | ||
| Board | Villy Helleskov | ||
| Board | Jørgen Winther Pedersen | ||
| Board | Arne Josefsen Rolighed | ||
| Board | Niels Stampe Rüdiger | ||
| Board | Carsten Kultoft Lorentsen | ||
| Board | Kurt Hedegaard Carstensen | ||
| Board | Torben Falck Ørntoft | ||
| Board | Lars Christian Caspersen | ||
| Board | Bruno Francis Claude Poddevin | ||
| Board | Thomas Gjelsnes | ||
| Board | Morten Melbye | ||
| Board | Stefánia Pcolová | ||
| Board | Michael Hadem | ||
| Board | Sonja Maria Wiedemann | ||
| Owner (100%) | Eurofins Genomics LUX Holding SARL | Current | |
| Owner (100%) | EUROFINS GENOMICS HOLDING DENMARK A/S | ||
| Auditor | DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB | Current | |
| Auditor | PRICEWATERHOUSECOOPERS SERVICES STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Auditor | PRICEWATERHOUSECOOPERS SERVICES STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Auditor | MJAKP2 I/S | ||
| Auditor | MJAKP P/S | ||
| Auditor | PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB | ||
| Founder | Torben Falck Ørntoft | Current | |
| Founder | Thomas Thykjær Andersen | Current | |
| Founder | Mogens Kruhøffer | Current | |
| Founder | ØSTJYSK INNOVATION A/S | Current |
The CEOs' other companies
Torben Falck Ørntoft – 6 other companies
- AAB PATENT HOLDING ApS Compulsorily dissolved
- FALCON HOLDING ApS Active
- INVESTERINGSSELSKABET AF 17.05.88 A/S Opløst
- PSYCHOGENETICS ApS Opløst
- Secec Aps Active
- ØSTJYSK INNOVATION A/S Fusioneret
Address history (3 moves)
| Smedeskovvej 38, 8464 Galten | |
| Palle Juul-Jensens Boulevard 82, 8200 Aarhus N | |
| Brendstrupgårdsvej 102, 8200 Aarhus N | |
| c/o Østjysk Innovation A/S, Gustav Wieds Vej 10, 8000 Århus C |
Former names
| Eurofins Genomics Denmark A/S | – now |
| Eurofins Genomics Europe AgriGenomics Products & Services A/S | – |
| Eurofins Genomics Europe Genotyping A/S | – |
| AROS APPLIED BIOTECHNOLOGY A/S | – |
| AROS APPLIED BIOTECHNOLOGY ApS | – |
Employees per year
Other companies at the same address
- AKTIESELSKABET AF 30. MAJ 2005 Opløst
- Aabybro Industrivej Real Estate ApS Active
- EUROFINS AGRO TESTING DENMARK A/S Active
- EUROFINS AGROSCIENCE SERVICES ApS Opløst
- EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S Active
- EUROFINS DANMARK AF 2002 A/S Fusioneret
- EUROFINS DANMARK AF 2003 A/S Fusioneret
- EUROFINS ENVIRONMENT DENMARK HOLDING ApS Active
- EUROFINS FOOD DENMARK HOLDING ApS Active
- EUROFINS GENOMICS HOLDING DENMARK A/S Fusioneret
- EUROFINS MILJØ A/S Active
- EUROFINS MILJØ LUFT A/S Active
- EUROFINS MILJØ VAND A/S Active
- EUROFINS NSC DENMARK ApS Active
- EUROFINS PRODUCT TESTING DENMARK A/S Active
- EUROFINS STEINS LABORATORIUM A/S Active
- EUROFINS TESTING A/S Opløst
- Eurofins BioPharma Product Testing Denmark Holding A/S Active
- Eurofins Genomics Denmark A/S Fusioneret
- Eurofins Milk Testing Denmark A/S Active
- Eurofins Professional Scientific Services Denmark A/S Fusioneret
- Eurofins Safer At Work Nordics A/S Fusioneret
- Eurofins VBM Geo ApS Fusioneret
- Eurofins VBM LABORATORIET A/S Active
- Eurofins Vitamin Testing Denmark A/S Active
Similar companies in Skanderborg
Questions and answers about Eurofins Genomics Denmark A/S
Has Eurofins Genomics Denmark A/S gone bankrupt?
No, Eurofins Genomics Denmark A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Eurofins Genomics Denmark A/S?
Our model estimates a bankruptcy risk of 0.1% over the next 12 months (low risk), which is 0.1 times the average for Danish companies.
Who is the auditor of Eurofins Genomics Denmark A/S?
Eurofins Genomics Denmark A/S most recently used DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB.
When was Eurofins Genomics Denmark A/S founded?
Eurofins Genomics Denmark A/S was founded on 1 November 2000.
What is the equity of Eurofins Genomics Denmark A/S?
Equity was DKK 14.2m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.